Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age? — Jiajie Hou (2021) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?
Shared by
Michael Karin
University of California, San Diego
Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?
Article
2021
en
Authors
JH
Jiajie Hou
Michael Karin
University of California, San Diego
BS
Beicheng Sun
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Chapter in a book
2004
Novel Anti-inflammatory Therapies
Peter J Barnes
,
Clive Page
Article
2025
Lessons from Glucocorticoids, Metformin, and Dimethyl Fumarate: Could Targeting Immunometabolism Lead to Better Anti-Inflammatory Therapies?
Vicki Evans
,
Luke O'neill
Article
1988
Oxidants, inflammation, and anti‐inflammatory drugs
Barry Halliwell
,
J.R.S. Hoult
,
David R. Blake
The FASEB Journal
Article
2020
Targeting immunometabolism as an anti-inflammatory strategy
Eva M. Pålsson‐McDermott
,
Luke O'neill
Cell Research
Article
2021
The neglected brothers come of age: B cells and cancer
Shabnam Shalapour
,
Michael Karin
Discussion(0)
No comments yet. Be the first to comment.